GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...

Mortality risk, especially due to dermatological and endocrine causes, was higher among patients with type 1 diabetes compared with type 2 diabetes.

An advancement in diabetes treatment has been achieved by Professor Hyun-Wook Kang and his team from the Department of ...

Drugs already taken by millions of diabetes patients appear to also help slash asthma attacks by up to 70%, new research ...

CGMs are prescribed to diabetics to monitor their blood sugar. They're now available and becoming wildly popular for over-the ...

For patients with diabetes, a systolic target of 120 mm Hg led to a significant reduction in CV events in BPROADS, mirroring ...

With an increasing burden of diabetes in Singapore, digital innovations, research can help diabetics manage better. Read more ...

The number of people living with diabetes worldwide has quadrupled in the past two decades, with 830 million people diagnosed ...

For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with ...

Following an impressive data drop this summer highlighting the potential for Eli Lilly’s tirzepatide to stave off progression ...